These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20513938)

  • 1. Pharmacogenetic application in personalized cancer treatment.
    Kristyanto H; Utomo AR
    Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in chemotherapy of colorectal cancer.
    Henriette Tanja L; Guchelaar HJ; Gelderblom H
    Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B; Carter A; Kristova V
    Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and personalised medicine: maintain a critical approach.
    Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
    Al-Salama HM; Johnstone EC; Kerr DJ
    Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using genetic variation to optimize cancer chemotherapy.
    McLeod HL; Papageorgio C; Watters JW
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.
    Dervieux T; Meshkin B; Neri B
    Mutat Res; 2005 Jun; 573(1-2):180-94. PubMed ID: 15829247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics in gastrointestinal tumors.
    Stöhlmacher J
    Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of colorectal cancer prevention and treatment.
    Nguyen H; Tran A; Lipkin S; Fruehauf JP
    Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genomic markers and anticancer chemotherapy].
    Nishiyama M
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personalized treatment of cancer: utopia or chance?].
    Thiel E
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinically relevant cancer biomarkers and pharmacogenetic assays.
    Patel JN; Mandock K; McLeod HL
    J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.